Medical Technology - Greece

  • Greece
  • The Medical Technology market market in Greece is expected to generate a revenue of US$1.96bn by 2024.
  • The largest market within this industry is Medical Devices, which is projected to reach a market volume of US$1.64bn in the same year.
  • Looking ahead, the market is anticipated to grow at an annual rate of 3.07% (CAGR 2024-2029), leading to a market volume of US$2.28bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue in the Medical Technology market sector, reaching US$210.00bn in 2024.
  • Greece is experiencing a surge in the adoption of advanced medical technology, revolutionizing healthcare delivery and improving patient outcomes.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Greece has been experiencing steady growth in recent years, driven by various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Medical Technology market in Greece have been shifting towards more advanced and innovative products. Greek consumers are becoming increasingly aware of the benefits of medical technology in improving healthcare outcomes and are willing to invest in high-quality medical devices and equipment. This preference for advanced technology is driving the demand for state-of-the-art medical devices in the Greek market. One of the key trends in the Medical Technology market in Greece is the increasing adoption of digital health solutions. The rise of telemedicine and remote patient monitoring has gained significant traction in recent years, especially in rural areas where access to healthcare facilities may be limited. The convenience and cost-effectiveness of digital health solutions have made them popular among both healthcare providers and patients in Greece. Another trend in the market is the growing demand for personalized medicine. Greek consumers are increasingly seeking tailored medical solutions that are specific to their individual needs. This has led to the development of innovative medical technologies, such as genetic testing and precision medicine, which aim to provide personalized treatment options for patients. Local special circumstances also play a role in the development of the Medical Technology market in Greece. The country's aging population is driving the demand for medical devices and equipment that cater to the needs of elderly patients. Additionally, the Greek government has been investing in the modernization of healthcare infrastructure, which has created opportunities for medical technology companies to introduce their products into the market. Underlying macroeconomic factors, such as the overall economic stability and government healthcare spending, also contribute to the growth of the Medical Technology market in Greece. Despite the economic challenges faced by the country in recent years, the healthcare sector has remained resilient, with the government prioritizing healthcare as an essential area for investment. This has created a favorable environment for medical technology companies to operate and expand their presence in Greece. In conclusion, the Medical Technology market in Greece is experiencing growth due to customer preferences for advanced and innovative products, the adoption of digital health solutions, the demand for personalized medicine, local special circumstances such as an aging population, and underlying macroeconomic factors that support healthcare investment. These factors have created opportunities for medical technology companies to thrive in the Greek market and contribute to the improvement of healthcare outcomes in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)